1      0

29.4 - Patients with advanced cirrhosis should receive blood products to correct coagulation abnormalities before invasive procedures

‐ May 1, 2021 2:30pm

Presentation Style: Debate

Learning Objectives:

  • Understand the balance between pro-hemorrhagic and pro-thrombotic tendencies in patients with cirrhosis at different stages
  • Understand the limitations of standard coagulation tests (INR, platelet count, fibrinogen) in predicting risk of post-procedural bleeding in patients with cirrhosis
  • Gain knowledge on the risk and potential benefits of blood product transfusion prior to invasive procedures in patients with cirrhosis